Back

MyD88 in myeloid cells promotes angiotensin II-induced vascular inflammation and is associated with all-cause mortality and incident heart failure in humans with arterial hypertension

27 August 2023 (16:45 - 16:55)
Organised by: Logo
Congress Presentation Part of: What’s new in hypertension? Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Philip Wenzel

Johannes Gutenberg University Mainz (JGU), Mainz (Germany)

2 More presentations in this session

Presentation thumbnail
Sympathetic nerve activity reactivity is associated with cardiac fibrosis in humans
Ms H. Blythe (Bristol, GB)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety aspects of renal denervation in treatment of arterial hypertension: a systematic review and meta-analysis
Doctor D. Vukadinovic (Homburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
What’s new in hypertension?
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 16:45 CET
You may be interested in
thumbnail
Congress Session
What’s new in hypertension?
thumbnail
Congress Session
Biomarkers and vascular mechanisms of hypertension and its organ damage
thumbnail
Congress Presentation
Conditional over-expression of heme-oxygenase 1 in myelomonocytic cells attenuates vascular inflammation and prevents the development of heart failure in mice with excess neurohormonal activation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources